Ose immunotherapeutics announces collaboration with microsoft

Nantes, france, june 16, 2022 (globe newswire) -- ose immunotherapeutics sa (isin: fr0012127173; mnemo: ose) today announces that the company is one of the first biotech startup companies selected by microsoft france to be a privileged partner of its support program for french biotech & deeptech startups. this program was launched during the 6th edition of “viva technology”, the most important startup and tech event organized in europe being held in paris from june 15-18, 2022.
MSFT Ratings Summary
MSFT Quant Ranking